Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2023 Mar 10:11:1115055.
doi: 10.3389/fpubh.2023.1115055. eCollection 2023.

Characterization and susceptibility of non-albicans Candida isolated from various clinical specimens in Lebanese hospitals

Affiliations
Observational Study

Characterization and susceptibility of non-albicans Candida isolated from various clinical specimens in Lebanese hospitals

Rola Husni et al. Front Public Health. .

Abstract

Background: Invasive fungal infections have presented a challenge in treatment. In the past, it was known that the frontrunner in such infections is Candida albicans with little emphasis placed on non-albicans Candida species (NAC). Studies worldwide have shown a rise in fungal infections attributed to non-albicans Candida species. The aim of this study is to describe the epidemiology of NAC infections along with an overview of resistance in Lebanese hospitals.

Methods: This is a two-year observational multi-central descriptive study. Between September 2016 and May of 2018, a total of 1000 isolates were collected from 10 different hospitals distributed all over the country. For the culture, Sabouraud Dextrose Agar was used. Antifungal Susceptibility was evaluated by determining the Minimum Inhibitory Concentration (MIC) in broth (microdilution) of the different antifungal treatments.

Results: Out of the 1000 collected isolates, Candida glabrata, being the most isolated species (40.8%), followed by Candida tropicalis: 231(23.1%), Candida parapsilosis: 103(10.3%), and other NAC species at lower percentage. Most of these isolates (88.67%) were susceptible to posaconazole, 98.22% were susceptible to micafungin, and 10% were susceptible to caspofungin.

Conclusion: The change of etiology of fungal infections involving a significant increase in NAC cases is alarming due to the different antifungal susceptibility patterns and the lack of local guidelines to guide the treatment. In this context, proper identification of such organisms is of utmost importance. The data presented here can help in establishing guidelines for the treatment of candida infections to decrease morbidity and mortality. Future surveillance data are needed.

Keywords: fungal infection; infection; microbiology; non-albicans Candida; pathogens.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Candida spp. isolated from various clinical specimens.

References

    1. Taei M, Chadeganipour M, Mohammadi R. An alarming rise of non-albicans Candida species and uncommon yeasts in the clinical samples; a combination of various molecular techniques for identification of etiologic agents. BMC Res Notes. (2019) 12:1–7. 10.1186/s13104-019-4811-1 - DOI - PMC - PubMed
    1. Suleyman G, Alangaden GJ. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infectious Disease Clinics. (2016) 30:1023–52. 10.1016/j.idc.2016.07.008 - DOI - PubMed
    1. Lim C-Y, Rosli R, Seow H, Chong P. Candida, and invasive candidiasis: back to basics. Eur J Clin Microbiol Infect Dis. (2012) 31:21–31. 10.1007/s10096-011-1273-3 - DOI - PubMed
    1. Benedict K, Richardson M, Vallabhaneni S, Jackson BR, Chiller T. Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks. Lancet Infect Dis. (2017) 17:e403–e11. 10.1016/S1473-3099(17)30443-7 - DOI - PMC - PubMed
    1. Johnson NB Hayes LD Brown K Hoo EC Ethier KA; Centers for Disease Control and Prevention (CDC) . CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors–United States, 2005–2013. MMWR Suppl. (2014) 63:3–27. - PubMed

Publication types

Substances